VOLITIONRX LTD Uncategorized Contracts & Agreements
49 Contracts & Agreements
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on May 11, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on May 11, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- Certain confidential information contained in this document, marked by [***], has been omitted because it (i) is not material and would be competitively harmful if publicly... (Filed With SEC on March 22, 2021)
- AMENDMENT #1 TO CLINICAL STUDY AGREEMENT (Filed With SEC on February 20, 2020)
- CLINICAL STUDY AGREEMENT (Filed With SEC on November 9, 2017)
- Offices of Matres Stphane Watillon & Pierre Hams, a partnership of notaries, in Namur Tel. 081/22.91.23 (Filed With SEC on May 13, 2016)
- FIRST AMENDMENT TO CONSULTANCY AGREEMENT (Filed With SEC on May 13, 2016)
- CONSULTANCY AGREEMENT (Filed With SEC on May 13, 2016)
- FIRST AMENDMENT TO EXECUTIVE CHAIRMANS AGREEMENT (Filed With SEC on May 13, 2016)
- Schedule no 1 to Master Consultancy Agreement between OncoLytika (the Consultancy) and Belgian Volition SA. (the Client) dated 01 January 2014 (the Master Agreement) (Filed With SEC on May 12, 2015)
- Schedule no 1 to Master Consultancy Agreement between OncoLytika (the Consultancy) and Volition (the Client) dated 01 October 2010 (the Master Agreement) (Filed With SEC on May 12, 2015)
- INDEPENDENT DIRECTOR AGREEMENT (Filed With SEC on May 12, 2015)
- EXECUTIVE CHAIRMANS AGREEMENT (Filed With SEC on May 12, 2015)
- VOLITIONRX LIMITED (Filed With SEC on January 23, 2015)
- Agreement (Filed With SEC on January 23, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 23, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 8, 2015)
- (1) PB COMMODITIES PTE LTD - and - (2) CAMERON REYNOLDS ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ (Filed With SEC on January 8, 2015)
- (1) VOLITIONRX LIMITED - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on January 8, 2015)
- (1) PB COMMODITIES PTE LTD - and - (2) CAMERON REYNOLDS ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ (Filed With SEC on January 8, 2015)
- (1) BELGIAN VOLITION S.A. - and - (2) BORLAUG LTD ___________________________________________ CONSULTANCY AGREEMENT ___________________________________________ Contents (Filed With SEC on April 1, 2013)
- Exhibit 10.27 (Filed With SEC on February 24, 2012)
- Exhibit 10.26 DATED: October 04, 2010 (1) PB COMMODITIES PTE LTD - and - (2) KENDALL LIFE SCIENCES CONSULTANTS LTD ___________________________________________ CONSULTANCY... (Filed With SEC on February 24, 2012)
- Exhibit 10.25 (Filed With SEC on February 24, 2012)
- Exhibit 10.24 (Filed With SEC on February 24, 2012)
- Exhibit 10.9 DATED 2010 (1) CHROMA THERAPEUTICS LIMITED - and - (2) VALIRX PLC - and - (3) VALIBIO SA - and - (4) SINGAPORE VOLITION PTE. LIMITED... (Filed With SEC on February 24, 2012)
- Exhibit 10.6 (Filed With SEC on February 24, 2012)
- Exhibit 10.5 (Filed With SEC on February 24, 2012)
- Exhibit 10.21 (Filed With SEC on January 11, 2012)
- Exhibit 10.20 (Filed With SEC on January 11, 2012)
- Exhibit 10.19 (Filed With SEC on January 11, 2012)
- Exhibit 10.18 (Filed With SEC on January 11, 2012)
- Exhibit 10.17 (Filed With SEC on January 11, 2012)
- Exhibit 10.16 DATED______________________________________________________________________2012 (1) IMPERIAL INNOVATIONS LIMITED - and - (2) VALIPHARMA LIMITED - and - (3)... (Filed With SEC on January 11, 2012)
- Exhibit 10.13 (Filed With SEC on January 11, 2012)
- Exhibit 10.12 (Filed With SEC on January 11, 2012)
- Exhibit 10.11 SINGAPORE VOLITION PTE. LIMITED (Filed With SEC on January 11, 2012)